Last reviewedSeptember 1, 2026
Reviewed byTortAdvisor Editorial Team
Primary-source standardJPML reports, federal court dockets and government sources
ImportantEducational information only — TortAdvisor is not a law firm

Reviewed Sept. 1, 2026 · TortAdvisor Editorial Team · Primary sources: JPML · Southern District of Illinois · EPA
Paraquat • Settlement Research • Updated September 2026

Paraquat Settlement Amounts 2026: MDL 3004 Status & Claim Value

A settlement structure exists in the paraquat litigation, but no amounts have been published — and the regulator that reviewed the science reached a different conclusion from the plaintiffs. Both facts belong on this page.

Quick AnswerNo paraquat settlement amounts have been disclosed. 6,666 actions were pending in MDL 3004 as of the Sept. 1, 2026 JPML report, before Judge Nancy J. Rosenstengel in the Southern District of Illinois, from 8,488 filed. A qualified settlement fund was established in 2026, but no tiers, criteria or per-claim values have been made public. Anyone assessing a claim should also know that EPA states it has not found a clear link between paraquat exposure from labeled uses and Parkinson’s disease — a position the plaintiffs contest and must overcome.
Primary sources onlyJPML reports, the MDL docket and EPA’s registration record
The science both waysWe report EPA’s finding as well as the plaintiffs’ case
Not a case valuationTortAdvisor is a research publisher, not a law firm
Rechecked Sept. 1, 2026Verified against the JPML report published that morning

Latest Paraquat Settlement Amounts and MDL 3004 Status

The paraquat litigation sits in an unusual position: a settlement structure has been put in place while the underlying scientific question remains contested, including by the federal regulator.

Where things stand on Sept. 1, 2026: MDL 3004 held 6,666 pending actions of 8,488 filed, before Judge Nancy J. Rosenstengel in the Southern District of Illinois. A qualified settlement fund has been established in the litigation, but no settlement amounts, allocation tiers or eligibility criteria have been made public. Separately, EPA’s registration review — running since 2011 and finalised as an interim decision in July 2021 — states the agency has not found a clear link between paraquat exposure from labeled uses and adverse health outcomes including Parkinson’s disease.
2011
EPA registration review opens

The agency begins its periodic reassessment of paraquat, which will run for more than a decade and become central to the litigation’s causation dispute.

Oct. 2019 – Oct. 2020
Draft risk assessments and proposed interim decision

EPA publishes its draft risk assessments and then a proposed interim decision, setting out its analysis of the epidemiology on Parkinson’s disease.

July 2021
Interim decision finalised

EPA finalises stronger exposure protections: aerial application limited to 350 acres per applicator per 24 hours, residential buffer zones, a prohibition on human flaggers, and restricted entry intervals of 48 hours for most crops.

2024
Volatilisation uncertainty identified

Syngenta submits new vapor pressure data in January. EPA’s March review finds greater uncertainty about paraquat volatilisation than previously estimated, reopening a question about off-target exposure.

Nov. 2025
EPA announces a Data-Call-In

The agency announces plans to require manufacturers to submit further data, with updated analysis to follow. The regulatory record on paraquat is therefore still open.

2026
Qualified settlement fund established

A fund is put in place in MDL 3004. No amounts, tiers or eligibility criteria have been published, so its existence signals structure rather than value.

Why the regulatory position matters to claim value. EPA reviewed hundreds of studies with conflicting results and concluded it had not found a clear link between labeled-use exposure and Parkinson’s disease, noting that a 2020 update to the Agricultural Health Study found no association where earlier 2011 findings had. Plaintiffs rely on other epidemiological and mechanistic evidence. A claimant should understand that this is a genuinely contested scientific question, not a settled one. Our paraquat lawsuit guide covers the litigation posture in more detail.
Paraquat claim stages — screening, filing, fact sheet, causation, resolution
How a claim moves through MDL 3004. General causation has been the decisive battleground.

Paraquat Settlement Amounts: Confirmed Facts vs. Contested Science

The docket facts are clear. The science is not, and pages that present it as settled are doing claimants no favours.

What Is Confirmed

  • MDL 3004 held 6,666 pending actions of 8,488 filed as of the Sept. 1, 2026 JPML report, before Judge Nancy J. Rosenstengel.
  • A qualified settlement fund has been established in the litigation.
  • EPA states it has not found a clear link between paraquat exposure from labeled uses and Parkinson’s disease or cancer.
  • A 2020 update to the Agricultural Health Study found no association between paraquat and Parkinson’s, contrasting with earlier 2011 findings.
  • Paraquat is a Restricted Use Pesticide; only trained certified applicators may use it, and — uniquely among restricted products — people working under a certified applicator’s supervision are prohibited from using it.
  • EPA’s 2021 interim decision imposed a 350-acre aerial limit per applicator per 24 hours, residential buffer zones, a ban on human flaggers and 48-hour restricted entry intervals for most crops.

What Is Not Known

  • How much is in the settlement fund, and who qualifies.
  • What any individual claim would be worth.
  • How the general causation dispute would resolve if cases are tried.
  • What EPA’s pending Data-Call-In analysis will conclude.
  • Whether off-target volatilisation exposure will support claims.
Any specific paraquat payout figure circulating today is an estimate, not an outcome. No settlement amounts have been published, no bellwether has produced a plaintiff verdict, and the regulator’s own position runs against the causation theory. Figures published elsewhere are not official settlement offers, historical averages or predictions.

Why This Page Publishes No Paraquat Payout Range

A settlement fund exists, which makes this the closest call in the library. It still does not support a published range.

A fund is not a figure

A qualified settlement fund is a mechanism for holding and distributing money. Nothing about its establishment discloses how much money, or how it would be allocated between claimants.

No criteria have been published

Where a programme publishes tiers — as the Roundup class settlement and the 9/11 fund do — this library reproduces them. Here there is nothing published to reproduce.

Causation remains genuinely contested

EPA has not found a clear link on labeled uses, and the epidemiology is mixed. A payout band implies a recovery the science has not yet secured.

What would have to exist before a credible range could be published: disclosed settlement tiers or criteria, a bellwether verdict, or a published allocation matrix. None of these exists as of Sept. 1, 2026. An actual outcome may be lower than figures published elsewhere, higher, or zero.
Paraquat settlement amounts factors — exposure duration, diagnosis, causation and applicator status
The factors that would drive value within any allocation. These are not weightings from a published matrix.
Payment mechanics

How a paraquat settlement payment would be calculated

A qualified settlement fund exists, so this sequence is closer to reality here than on most pages in this library. The amounts are still unknown.

1

Claim assessed against agreed criteria

Exposure duration and intensity, applicator status, diagnosis and staging are weighed.

2

Attorney fees and case costs deducted

Contingency fee plus filing, expert and record-retrieval costs come out first.

3

Liens and reimbursements resolved

Medicare, Medicaid and private insurers recover what they paid for Parkinson’s treatment.

4

Net payment issued from the fund

The fund holds and distributes the money once allocation is determined.

Illustrative sequence only. No paraquat settlement amounts, tiers or eligibility criteria have been published as of Sept. 1, 2026.

How TortAdvisor Handles Paraquat Settlement Amounts

On a tort where the regulator disagrees with the plaintiffs, the editorial obligation is to say so rather than quietly omit it.

01

Report the regulator’s position

EPA’s conclusion that it has not found a clear link is material to anyone assessing a claim, and appears here rather than being left out because it is unhelpful.

02

A fund is not an amount

The establishment of a qualified settlement fund is reported as exactly that, without inferring a value that has not been disclosed.

03

Distinguish exposure routes

Applicator exposure, bystander exposure and off-target drift raise different evidentiary questions and are not blended together.

04

Track the current docket

Case counts come from the current month’s JPML report rather than a figure repeated across secondary sites after it went stale.

Editorial methodology: TortAdvisor separates confirmed facts from estimates and avoids describing projections as settlements. See how TortAdvisor compiles settlement and verdict estimates.
How a paraquat settlement payment would reach a claimant — allocation, fees, liens, net
Illustrative sequence only. No paraquat allocation criteria have been published as of Sept. 1, 2026.

The Paraquat Science, On Both Sides

Claim value in this litigation depends on a scientific dispute. Presenting only one side of it would misrepresent the risk a claimant is taking.

Question EPA’s stated position The plaintiffs’ case
Does labeled-use exposure cause Parkinson’s? After reviewing hundreds of studies with conflicting results, EPA states it has not found a clear link Plaintiffs rely on other epidemiological and mechanistic evidence linking paraquat to dopaminergic neuron damage
The Agricultural Health Study A 2020 update found no association between paraquat and Parkinson’s, contrasting with earlier 2011 findings Plaintiffs point to methodological limitations and to studies outside that cohort
Exposure beyond the label EPA’s 2021 decision imposed stronger protections, implying exposure risk was being managed Plaintiffs argue real-world mixing, loading and drift exposure exceeded labeled assumptions
Volatilisation and drift EPA’s 2024 review found greater uncertainty about volatilisation than previously estimated That uncertainty supports arguments about off-target and bystander exposure
Is the record closed? No — EPA announced in November 2025 that it would require further data from manufacturers A changing regulatory record can cut either way for pending claims

This table is not a prediction about who is right. It is the state of a live scientific dispute, and it is the reason no responsible payout range can be published for this tort today.

Who May Qualify for Paraquat Settlement Amounts

Eligibility turns on documented exposure and a neurologist-confirmed diagnosis, and the exposure side is where most claims are tested.

Common Screening Factors

  • A Parkinson’s disease diagnosis confirmed by a neurologist
  • Occupational exposure through mixing, loading or applying paraquat
  • Certification as a restricted-use pesticide applicator, which is strong documentary evidence
  • Farm work, agricultural contracting or groundskeeping in areas where paraquat was applied
  • Living or working adjacent to treated fields, for drift and bystander claims
  • Claims brought by a personal representative where the claimant has died

Factors Requiring Closer Review

  • Exposure that cannot be documented beyond recollection
  • Parkinsonism from another identified cause, or an atypical diagnosis
  • Family history of Parkinson’s, head injury or other risk factors raised by the defence
  • Latency that does not fit the causation argument
  • State limitation periods, which usually run from diagnosis

For the closest comparison in this library — an agricultural chemical where a class settlement does publish figures — see our Roundup settlement amounts research, and for the wider category our toxic exposure lawsuit research.

Factors That Would Affect Paraquat Settlement Amounts

With no published criteria, these are the factors that determine whether a paraquat claim is strong.

Duration and intensity of exposure

Years of mixing, loading and spraying carry far more weight than incidental or single-season contact. Frequency and handling role both matter.

Certified applicator status

Because only certified applicators may legally use paraquat, state licensing records are unusually strong documentary proof of exposure.

Diagnosis and staging

A neurologist-confirmed Parkinson’s diagnosis, with clinical staging and documented functional decline over time.

Age at onset

Younger onset carries more years of impairment, care need and lost earning capacity, and is also harder for the defence to attribute to ageing.

Latency between exposure and onset

The interval must be consistent with the causation theory. Onset very shortly after first exposure, or many decades later, invites challenge.

Competing risk factors

Family history, head trauma and other pesticide exposures are the standard defence arguments and are supported by EPA’s own stated position.

Causation is the whole case here. Unlike torts where liability is largely settled and only value is in dispute, a paraquat claim must first establish that the exposure caused the disease — against a regulatory record that says no clear link has been found. That risk sits behind every figure anyone quotes.

Evidence Supporting Paraquat Settlement Amounts

Documented exposure is what separates a viable paraquat claim from an account of having worked on a farm.

Applicator licence records

State pesticide applicator certification records. Because supervised use is prohibited, licensing is strong evidence of who actually handled the product.

Employment and farm records

Which farms or operations, which years, and what role. Payroll records, contracts and tax records all help place a claimant on specific land.

Purchase and supply records

Invoices, co-op accounts and dealer records identifying paraquat specifically rather than herbicides generally.

Neurology records

The Parkinson’s diagnosis, the diagnosing neurologist, clinical staging, imaging and response to treatment.

Treatment history

Medication regimens, dose escalation, deep brain stimulation and documented functional decline over time.

Co-worker testimony

Colleagues who can confirm mixing and loading practice, protective equipment used, and how often spraying was done.

Paraquat settlement amounts evidence checklist — exposure proof, diagnosis and treatment records
The records behind paraquat settlement amounts. Applicator licensing is the strongest exposure proof available.

Filing Deadlines for Paraquat Claims

The settlement fund does not create a deadline anyone outside the litigation can see. State limitation periods do, and they run from diagnosis.

In most states the clock starts at the Parkinson’s diagnosis, not at exposure. Because exposure typically predates onset by many years, a discovery rule is what makes these claims possible at all. Those periods are often two to three years, and wrongful death claims run separately from the date of death. Nothing about the existence of a qualified settlement fund extends them.

What tends to matter

  • The date of diagnosis and which state’s law governs
  • Whether a discovery rule applies and when it started the clock
  • Whether the claim is an injury claim or a wrongful death claim
  • Whether exposure records still exist and can be obtained

What does not pause the clock

  • The existence of the qualified settlement fund
  • Waiting for allocation criteria to be published
  • EPA’s pending Data-Call-In and further review
  • Continuing Parkinson’s treatment
A missed deadline ends a claim regardless of how well documented the exposure is. Nothing on this page establishes a deadline for any individual, and only a licensed attorney in the relevant state can confirm which period applies.

Take the Paraquat Settlement Calculator Below

The calculator organises what you know about exposure, applicator status, the diagnosis, treatment and financial loss, then shows which factors carry the most weight in a paraquat claim. It takes a few minutes and asks for no documents.

The result is educational and is not a guaranteed case value or settlement offer.

Before You Start

  • Roughly which years paraquat was used or encountered
  • Whether you held an applicator certification
  • Whether you mixed and loaded, or only worked nearby
  • When Parkinson’s was diagnosed, and by whom
  • Treatment received so far
  • The state where the exposure occurred

Answer what you know. You do not need every record or an exact timeline to get started.

Primary Sources for Paraquat Settlement Amounts

Every fact above traces to one of these. Each was checked on Sept. 1, 2026.

JPML pending-actions report

The JPML report dated Sept. 1, 2026 lists 6,666 actions pending in MDL 3004 of 8,488 filed, before Judge Nancy J. Rosenstengel in the Southern District of Illinois.

EPA paraquat registration record

EPA’s paraquat dichloride page sets out the registration review timeline from 2011, the July 2021 interim decision and its protections, the agency’s statement that it has not found a clear link to Parkinson’s from labeled uses, the 2020 Agricultural Health Study update, the 2024 volatilisation finding and the November 2025 Data-Call-In announcement.

Restricted use classification

EPA classifies all U.S. paraquat products as Restricted Use Pesticides usable only by trained certified applicators, and uniquely prohibits use by people working under a certified applicator’s supervision — a fact that makes applicator licensing records central to proving exposure.

The MDL 3004 docket

The qualified settlement fund and case management orders are recorded on the Southern District of Illinois docket. TortAdvisor cites the docket rather than secondary coverage of it.

Why no payout figure is cited

No settlement amounts, tiers or eligibility criteria have been published, and no bellwether has produced a plaintiff verdict. TortAdvisor therefore publishes no paraquat payout range.

On reporting the science both ways

EPA’s position is adverse to the plaintiffs’ causation theory. It appears on this page because a claimant deciding whether to pursue a claim needs to know the strongest argument against it, not only the case for it.

Frequently Asked Questions About Paraquat Settlement Amounts

What is the average paraquat settlement amount?

There is no average. No settlement amounts, tiers or allocation criteria have been published, and no bellwether has produced a plaintiff verdict. Figures circulating elsewhere are estimates rather than outcomes.

Is there a paraquat settlement fund?

A qualified settlement fund has been established in MDL 3004. That is a vehicle for holding and distributing money — it does not disclose how much money, who qualifies, or what any claim is worth.

How many paraquat lawsuits are pending?

The JPML report dated Sept. 1, 2026 lists 6,666 actions pending in MDL 3004 of 8,488 filed, before Judge Nancy J. Rosenstengel in the Southern District of Illinois.

Does EPA say paraquat causes Parkinson’s disease?

No. EPA states that after reviewing hundreds of studies with conflicting results it has not found a clear link between paraquat exposure from labeled uses and adverse health outcomes such as Parkinson’s disease and cancer. Plaintiffs contest that conclusion and rely on other evidence.

Who is allowed to use paraquat?

Only trained certified applicators. All U.S. paraquat products are Restricted Use Pesticides, and unusually, people working under a certified applicator’s supervision are prohibited from using it — which is why licensing records matter so much to these claims.

Can I claim for exposure if I never applied it myself?

Possibly. Bystander and drift claims are brought by people who lived or worked near treated fields. They are harder to document, though EPA’s own 2024 finding of greater uncertainty about volatilisation is relevant to that argument.

When does the filing deadline run from?

In most states from the Parkinson’s diagnosis rather than from exposure, under a discovery rule. Those periods are often two to three years, and they are not extended by the existence of the settlement fund.

Is the paraquat settlement calculator legally binding?

No. It is an educational tool that organises claim factors into an illustrative range. It is not a case valuation, not an offer, and binds no defendant, court or law firm.

Free Educational Settlement Calculator

See Which Factors May Affect a Paraquat Parkinson’s Claim

Answer the questions you can about paraquat exposure, a Parkinson’s diagnosis, treatment, records, expenses and long-term impact. The calculator organizes those inputs into an educational settlement range and highlights the factors that may matter most when a claim is reviewed.

The result is educational and is not a guaranteed case value or settlement offer.

Private CalculatorNo login is required to use the estimator. Free to UseThere is no fee to complete the calculator. Claim-Factor BasedInjury, treatment, records and damages affect the estimate. No ObligationUsing the calculator does not create representation.

Helpful Information to Have Ready

You do not need every record in hand. Answer what you know; these details can make the estimate more useful.

Years of exposureApplicator certificationParkinson’s diagnosisNeurology recordsFarms and job sitesBills & lost earnings

Before you begin: This calculator uses limited user-entered information and TortAdvisor editorial assumptions. It does not determine liability, legal eligibility, filing deadlines, attorney acceptance or compensation. The result is educational and is not a guaranteed case value or settlement offer.
Answer these few questions about the paraquat-related Parkinson’s claim Answer what you know. You do not need every record or an exact timeline to get started.


Receiving a calculator result is separate from any optional request to be contacted. Any optional consent checkbox should remain unchecked unless you affirmatively select it.

About the TortAdvisor Editorial Team

TortAdvisor has worked in the mass tort and personal injury space for more than 15 years, alongside some of the most respected plaintiffs’ attorneys in the country. That experience is what these guides are built on. We have seen which settlement figures hold up when a claim is actually reviewed and which ones came from a press release, and we write these pages for the reader who needs to tell the difference.

Every figure here traces to a court order, a government filing or an official settlement programme. For this guide that means the JPML’s monthly pending-actions reports, the MDL 3004 docket in the Southern District of Illinois, and EPA’s paraquat dichloride registration record. Editorial projections are labelled as projections, never as averages or reported outcomes, and time-sensitive facts — case counts, hearing dates, court rulings — are rechecked against primary sources rather than repeated from other websites. Where the public record supports no figure at all, we say so instead of estimating.

TortAdvisor is a legal research publisher, not a law firm. We do not represent claimants, give legal advice, accept cases or review claims. Our purpose is to help you understand what the public record actually shows before you speak with an attorney of your own choosing. See our editorial policy and our settlement data methodology for how these guides are compiled and corrected.

LEGAL, MEDICAL, ADVERTISING AND SETTLEMENT-ESTIMATE DISCLAIMER: This page and calculator provide general educational information and illustrative estimates. They do not provide legal advice, medical advice, a case valuation, a settlement offer or a guarantee of eligibility, representation, filing, settlement, trial or compensation. Allegations in MDL 3004 remain disputed. Viewing this page, using the calculator, calling or submitting information does not create an attorney-client relationship. Attorney advertising rules, filing deadlines, recoverable damages and legal standards vary by jurisdiction. Do not stop or change any prescribed Parkinson’s treatment based on litigation coverage, and speak first with a qualified healthcare professional. Seek prompt advice from licensed legal and medical professionals regarding your circumstances.

⚡ Free Confidential Case Evaluation

No fee unless you win · Open 24/7 · Completely confidential

Legal Disclaimer:By clicking "Submit My Case Evaluation," I provide my electronic signature and agree that TortAdvisor, operated by Waypoint Software LLC, and the law firms or marketing partners identified in the Partner List may call, text, or email me about my inquiry at the number and email I provide, including through automated technology, artificial or prerecorded voice, and SMS. Consent is not a condition of purchase or legal services. Message and data rates may apply. Reply STOP to opt out of SMS. I agree to the Terms and Privacy Policy.

TortAdvisor Editorial Team

About TortAdvisor Editorial Team